Comment from alfredo irazabal

Summary: Alfredo Arizabal, an independent dentist, supports the inclusion of several peptides on the 503A Bulk Drug Substances List but argues that the FDA must mandate strict Good Manufacturing Practice (GMP) standards for their production. He also requests clarification on the "wound healing" indication for BPC-157 to ensure it covers internal tissue repair and asks for the expansion of MOTs-C's indications to include Type 2 Diabetes.